Postdoctoral– Structural Biology and Drug Design: The University of Queensland is seeking a talented Postdoctoral Research Fellow to join a dynamic team focused on structural biology and structure-guided inhibitor design. The successful candidate will work on characterizing protein complexes involved in signaling pathways crucial to inflammation and neurodegeneration, contributing to the development of anti-inflammatory therapeutics.
Postdoctoral Research Fellow – Structural Biology and Drug Design
Designation: Postdoctoral Research Fellow
Research Area: Structural Biology and Drug Design
Location: St Lucia Campus, University of Queensland
Eligibility/Qualification:
- Completion or near completion of a PhD in the discipline area
- Demonstrated research achievements including publications in reputable journals and conference presentations
- Experience in securing external research funding is advantageous
- Involvement in internal service roles and external activities is desirable
Job Description:
- Conduct research as agreed with the supervisor in the field of structural biology and structure-guided inhibitor design.
- Produce high-quality research outputs including scholarly papers and conference presentations.
- Collaborate with colleagues on joint research projects and funding applications.
- Assist in translating research findings into real-world applications and commercializing intellectual property.
- Develop a research program and profile, utilizing best practice research methodologies.
- Play a role in supervising Honours and Higher Degree by Research students.
How to Apply:
To apply for this position, please upload the following documents:
- Resume
- Cover letter addressing the ‘About You’ section
For further information or to apply, email Professor Bostjan Kobe at b.kobe@uq.edu.au. For application queries, contact talent@uq.edu.au stating the job reference number (R-40802) in the subject line.
Last Date for Apply:
Applications close on August 13, 2024, at 11:00 pm AEST (R-40802). Interview tentative dates are scheduled for late August/early September 2024.
Feel free to reach out for any additional clarifications or details regarding this exciting opportunity.
